. Corrigendum to 'Neuroprotective effects of ginsenoside Rg1 through the Wnt/β-catenin signaling pathway in both in vivo and in vitro models of Parkinson's disease'[Neuropharmacology, 101 (2016) 480-489 /Article Number: NEUROPHARM-D-15-00626]. Neuropharmacology. 2024 Dec 9;:110260. Epub 2024 Dec 9 PubMed. Corrected paper.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.